Clinical Trial Update: A Study of Neoadjuvant Letrozole + Taselisib Versus Letrozole + Placebo in Post-Menopausal Women With Breast Cancer (LORELEI) [Phase 2]

View source ↗

Summary

A Phase 2 neoadjuvant trial comparing letrozole plus taselisib with letrozole plus placebo in postmenopausal women with breast cancer. The study completed and r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• FEMARA (letrozole)
• Taselisib (GDC-0032)

Snippet

Sponsor: Genentech, Inc. | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED | Results posted: 2018-05-21